生物活性 | |||
---|---|---|---|
描述 | PF-04802367 is a highly selective GSK-3 inhibitor with an IC50 of 2.1 nM in the recombinant human GSK-3β enzyme assay and 1.1 nM in the ADP-Glo assay. PF-04802367 inhibits the two known GSK-3 isoforms, GSK-3α and GSK-3β, with identical IC50 values in mobility shift assays. The IC50 values of PF-04802367 were 10.0 and 9.0 nM in the mobility shift assay, respectively. PF-04802367 has reasonable in vitro stability in human liver microsomes (t1/2=78.7 min) and excellent passive permeability. In a stably induced CHO cell line overexpressing GSK-3β and its substrate tau, PF-04802367 inhibited tau phosphorylation with an IC50 of 466 nM[1].PF-04802367 had a significant right-shifting effect on β-catenin translocation in HeLa cells (EC50 of 6.2 μM), gene transcription in U20S cells (EC50 of 20.6 μM) and cell proliferation in HeLa cells (EC50 of 9.0 μM)[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.76mL 0.55mL 0.28mL |
13.82mL 2.76mL 1.38mL |
27.64mL 5.53mL 2.76mL |
参考文献 |
---|